1o4c: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1o4c.png|left|200px]] | [[Image:1o4c.png|left|200px]] | ||
{{STRUCTURE_1o4c| PDB=1o4c | SCENE= }} | {{STRUCTURE_1o4c| PDB=1o4c | SCENE= }} | ||
===CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.=== | ===CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.=== | ||
{{ABSTRACT_PUBMED_14613321}} | {{ABSTRACT_PUBMED_14613321}} | ||
== | ==About this Structure== | ||
[[1o4c]] is a 1 chain structure of [[Proto-oncogene tyrosine-protein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1O4C OCA]. | |||
== | ==See Also== | ||
*[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:014613321</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Line 33: | Line 21: | ||
[[Category: Loenze, P.]] | [[Category: Loenze, P.]] | ||
[[Category: Sh2 domain fragment approach]] | [[Category: Sh2 domain fragment approach]] | ||
[[Category: Signaling protein]] | |||
Revision as of 15:47, 25 July 2012
CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.
Template:ABSTRACT PUBMED 14613321
About this StructureAbout this Structure
1o4c is a 1 chain structure of Proto-oncogene tyrosine-protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Lange G, Lesuisse D, Deprez P, Schoot B, Loenze P, Benard D, Marquette JP, Broto P, Sarubbi E, Mandine E. Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors. J Med Chem. 2003 Nov 20;46(24):5184-95. PMID:14613321 doi:http://dx.doi.org/10.1021/jm020970s